302 related articles for article (PubMed ID: 9777982)
21. Evaluation of 12 antibodies for distinguishing epithelioid mesothelioma from adenocarcinoma: identification of a three-antibody immunohistochemical panel with maximal sensitivity and specificity.
Yaziji H; Battifora H; Barry TS; Hwang HC; Bacchi CE; McIntosh MW; Kussick SJ; Gown AM
Mod Pathol; 2006 Apr; 19(4):514-23. PubMed ID: 16554731
[TBL] [Abstract][Full Text] [Related]
22. Expression of calretinin and other mesothelioma-related markers in thymic carcinoma and thymoma.
Pan CC; Chen PC; Chou TY; Chiang H
Hum Pathol; 2003 Nov; 34(11):1155-62. PubMed ID: 14652817
[TBL] [Abstract][Full Text] [Related]
23. So-called peritoneal implants of ovarian carcinomas. Problems in differential diagnosis.
Dienemann D; Pickartz H
Pathol Res Pract; 1987 Apr; 182(2):195-201. PubMed ID: 3601795
[TBL] [Abstract][Full Text] [Related]
24. Calretinin, thrombomodulin, CEA, and CD15: a useful combination of immunohistochemical markers for differentiating pleural epithelial mesothelioma from peripheral pulmonary adenocarcinoma.
Comin CE; Novelli L; Boddi V; Paglierani M; Dini S
Hum Pathol; 2001 May; 32(5):529-36. PubMed ID: 11381372
[TBL] [Abstract][Full Text] [Related]
25. Immunophenotypings of malignant epithelial mesothelioma and their roles in the differential diagnosis.
Ruan Q; Hu Y
J Huazhong Univ Sci Technolog Med Sci; 2004; 24(2):112-5. PubMed ID: 15315156
[TBL] [Abstract][Full Text] [Related]
26. Peritoneal serous papillary adenocarcinoma: report of four cases.
Minami T; Nakatani K; Kondo S; Kanayama S; Tsujimura T
Intern Med; 2005 Sep; 44(9):944-8. PubMed ID: 16258208
[TBL] [Abstract][Full Text] [Related]
27. BAP1 and Claudin-4, But Not MTAP, Reliably Distinguish Borderline and Low-grade Serous Ovarian Tumors From Peritoneal Mesothelioma.
Devins KM; Zukerberg L; Watkins JC; Hung YP; Oliva E
Int J Gynecol Pathol; 2023 Mar; 42(2):159-166. PubMed ID: 35512220
[TBL] [Abstract][Full Text] [Related]
28. Is PAX2 a reliable marker in differentiating diffuse malignant mesotheliomas of peritoneum from serous carcinomas of müllerian origin?
Gao FF; Krasinskas AM; Chivukula M
Appl Immunohistochem Mol Morphol; 2012 May; 20(3):272-6. PubMed ID: 22498671
[TBL] [Abstract][Full Text] [Related]
29. Complementary value of five carcinoma markers for the diagnosis of malignant mesothelioma, adenocarcinoma metastasis, and reactive mesothelium in serous effusions.
Delahaye M; van der Ham F; van der Kwast TH
Diagn Cytopathol; 1997 Aug; 17(2):115-20. PubMed ID: 9258618
[TBL] [Abstract][Full Text] [Related]
30. Varieties of serous surface papillary carcinoma of the peritoneum in northern Germany: a thirty-year autopsy study.
Rothacker D; Möbius G
Int J Gynecol Pathol; 1995 Oct; 14(4):310-8. PubMed ID: 8598333
[TBL] [Abstract][Full Text] [Related]
31. Primary papillary serous neoplasia of the peritoneum: a clinicopathologic and ultrastructural study of eight cases.
Raju U; Fine G; Greenawald KA; Ohorodnik JM
Hum Pathol; 1989 May; 20(5):426-36. PubMed ID: 2707793
[TBL] [Abstract][Full Text] [Related]
32. Longitudinal CA125 detection of sporadic papillary serous carcinoma of the peritoneum.
Skates S; Troiano R; Knapp RC
Int J Gynecol Cancer; 2003; 13(5):693-6. PubMed ID: 14675358
[TBL] [Abstract][Full Text] [Related]
33. A comparative immunohistochemical study of malignant mesothelioma and renal cell carcinoma: the diagnostic utility of Leu-M1, Ber EP4, Tamm-Horsfall protein and thrombomodulin.
Attanoos RL; Goddard H; Thomas ND; Jasani B; Gibbs AR
Histopathology; 1995 Oct; 27(4):361-6. PubMed ID: 8847067
[TBL] [Abstract][Full Text] [Related]
34. Primary peritoneal serous papillary carcinoma: a clinical and pathological study.
Liu Q; Lin JX; Shi QL; Wu B; Ma HH; Sun GQ
Pathol Oncol Res; 2011 Sep; 17(3):713-9. PubMed ID: 21647781
[TBL] [Abstract][Full Text] [Related]
35. Loss of BAP1 expression is very rare in peritoneal and gynecologic serous adenocarcinomas and can be useful in the differential diagnosis with abdominal mesothelioma.
Andrici J; Jung J; Sheen A; D'Urso L; Sioson L; Pickett J; Parkhill TR; Verdonk B; Wardell KL; Singh A; Clarkson A; Watson N; Toon CW; Gill AJ
Hum Pathol; 2016 May; 51():9-15. PubMed ID: 27067777
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of PAS-diastase and carcinoembryonic antigen staining in the differential diagnosis of malignant mesothelioma and papillary serous carcinoma of the ovary.
Silcocks PB; Herbert A; Wright DH
J Pathol; 1986 Jun; 149(2):133-41. PubMed ID: 2426430
[TBL] [Abstract][Full Text] [Related]
37. Diagnostic significance of carcinoembryonic antigen in the differential diagnosis of malignant mesothelioma.
Mezger J; Lamerz R; Permanetter W
J Thorac Cardiovasc Surg; 1990 Dec; 100(6):860-6. PubMed ID: 2147220
[TBL] [Abstract][Full Text] [Related]
38. Well-Differentiated Papillary Mesothelioma with Omental Calcifications: A Case Report and Review of the Literature.
Erem AS; Allamaneni SS; Braverman TS
Am J Case Rep; 2020 Jan; 21():e920487. PubMed ID: 31929500
[TBL] [Abstract][Full Text] [Related]
39. Rab25 is overexpressed in Müllerian serous carcinoma compared to malignant mesothelioma.
Brusegard K; Stavnes HT; Nymoen DA; Flatmark K; Trope CG; Davidson B
Virchows Arch; 2012 Feb; 460(2):193-202. PubMed ID: 22249560
[TBL] [Abstract][Full Text] [Related]
40. 'Mucin-positive' epithelial mesothelioma of the peritoneum: an unusual diagnostic pitfall.
Cook DS; Attanoos RL; Jalloh SS; Gibbs AR
Histopathology; 2000 Jul; 37(1):33-6. PubMed ID: 10931216
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]